Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
This guide covers withdrawal-friendly total market ETFs and how to structure distributions to maximize cash flow while controlling taxes in retirement.
28,154 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
One year after the pledge, the Strategic Petroleum Reserve remains short of full capacity while crude prices push pas...
Mid-term rentals are moving into the spotlight for investors seeking steady cash flow with manageable risk. This guid...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Big tech’s heavy AI investments are pinching buyback payouts, reshaping capital allocation as investors weigh dividen...
Ripple has lined up a wave of partnerships with global banks in 2026, but XRP prices haven’t reflected the wins. Here...
As Greg Abel steers Berkshire Hathaway's non-insurance businesses, Berkshire Hathaway Energy could emerge as a reliab...
A regulatory nod sparks a wave of excitement across crypto markets. Perpetual futures are back in the spotlight as tr...
Walmart faces a pivotal moment as macro headwinds collide with a fast-growing digital ecosystem. This report examines...
Nvidia dominates AI hardware, but timing a stock move before a key date is tricky. This guide breaks down when to buy...
SpaceX stock shines in the headlines, but the math behind the hype isn’t adding up for me. Here are four practical re...